Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. Guided by our core values, Stay True to Why, Collaborate to Accelerate, Lead with Clarity, Boldly Innovative, and Own the Outcome, we are committed to transforming the future of treatment for autoimmune disease. Join us at the forefront of cell therapy innovation and help redefine what’s possible.
Position Overview
Kyverna Therapeutics is seeking a highly motivated, hands-on, and detail-oriented Associate Director, SEC Reporting & Technical Accounting to join the Finance organization reporting to the VP, Corporate Controller. This individual will play a critical role in leading the Company’s SEC reporting, technical accounting, SOX compliance, and operational accounting activities within a dynamic and rapidly evolving public biotechnology environment.
This position is ideal for a proactive CPA with deep expertise in U.S. GAAP and SEC reporting, including candidates with a strong foundation in public accounting, audit, or accounting advisory services who are seeking broader exposure across operational and strategic accounting functions within the life sciences industry.
The successful candidate will partner cross-functionally with Finance, Legal, HR, IT, Stock Administration, Investor Relations, external auditors, and third-party advisors while supporting the Company’s continued growth, governance initiatives, and commercial readiness efforts.
Department: Finance
Location: Remote eligible
Reports To: VP, Accounting & Business Operations
Responsibilities
- Lease accounting (ASC 842)
- Share-based compensation (ASC 718)
- Available-for-sale investments
- Statement of cash flows
- Stockholders’ equity roll forwards
SEC Reporting & Financial Reporting
• Lead the preparation and review of quarterly and annual SEC filings, including Forms 10-Q, 10-K, 8-K, S-8, supporting disclosures, and related tie-out documentation and reporting workbooks
• Prepare and review key financial statement areas and disclosures, including:
• Manage the Company’s quarterly and annual reporting calendar and coordinate cross-functional deliverables with Legal, Investor Relations, Finance, and external stakeholders to ensure timely and accurate SEC filings
• Serve as a key point of contact for external auditors and SOX auditors in connection with quarterly reviews, annual audits, and ongoing compliance activities
• Assist in the preparation of Audit Committee and Disclosure Committee materials and presentations, as needed
• Lead and coordinate SOX compliance initiatives, partnering with internal process owners, external auditors, and SOX consultants to support ongoing compliance and control effectiveness
• Maintain and enhance SOX documentation, including narratives, process flows, and risk control matrices (RCMs)
Technical Accounting
• Research, analyze, and document technical accounting conclusions under U.S. GAAP for complex and non-routine transactions
• Prepare technical accounting memoranda and supporting analyses related to lease accounting under ASC 842, including lease modifications and reassessments
• Partner with the VP, Corporate Controller and third-party advisors on technical accounting assessments related to financing transactions, strategic agreements, and other complex accounting matters
• Support operational and cross-functional teams with technical accounting guidance related to inventory, cost capitalization, debt accounting, collaboration agreements, new accounting pronouncements, and other business initiatives
• Perform technical accounting calculations and analyses related to share-based compensation accounting under ASC 718, including equity award modifications and Black-Scholes fair value calculations
• Conduct quarterly contract reviews to identify accounting implications and ensure appropriate accounting treatment and documentation
Operational & Strategic Support
• Support selected stock administration and payroll-related accounting review activities
• Assist with accounting and reporting for debt and equity financings, licensing and collaboration agreements, and other strategic transactions
• Participate in process improvement initiatives, automation efforts, and system implementations to support scalability and operational efficiency within a growing public company environment
• Contribute to ad hoc analyses, special projects, and broader Finance organization initiatives, as needed
Qualifications
• Bachelor’s degree in Accounting or Finance required
• Active CPA license required
• 10+ years of progressive accounting experience, including experience serving SEC registrants within public accounting and/or accounting advisory environments
• Big Four or national public accounting firm experience strongly preferred
• Strong technical knowledge of U.S. GAAP, SEC reporting requirements, and public company compliance obligations
• Demonstrated experience preparing technical accounting memoranda and analyzing complex accounting transactions
• Experience supporting SOX 404(b) compliance programs and internal control frameworks
• Biotechnology, pharmaceutical, or life sciences industry experience preferred, but not required
• Strong Excel, financial systems, and reporting tool experience; Workiva experience is a plus
• Excellent organizational, project management, and communication skills with the ability to manage multiple priorities in a fast-paced environment
• Collaborative, team-oriented mindset with a willingness to roll up sleeves and support broader team initiatives
• Ability to remain highly detail-oriented, hands-on, and execution-focused while operating strategically in a growing organization
Skills Required
- Bachelor's degree in Accounting or Finance
- Active CPA license
- 10+ years of progressive accounting experience
- Experience serving SEC registrants
- Strong technical knowledge of U.S. GAAP and SEC reporting
- Experience with SOX compliance programs
What We Do
Kyverna is a cell therapy company engineering and developing a new class of curative living medicines for inflammatory and autoimmune diseases. Using its SmarTcell™ approach which includes synReg-T cell and synNotch CAR-T technology platforms, Kyverna reprograms T cells to target and selectively suppress or eliminate autoreactive immune cells. The company’s goal is to develop therapies that are selective, potent and durable to tame autoimmunity. We build interdisciplinary teams that bring a broad range of experiences and scientific expertise together to develop medicines that will free patients from the siege of autoimmune diseases and bring curiosity for exploring and creating the unknown. Our commitment to our employees is to foster an open, supportive, and inclusive environment where we create opportunities for individuals to learn and grow to their full potential at every level. synNotch is a trademark of Gilead/Kite.
.png)
